Key Findings: Asian participants: 21.3% mean weight loss with CagriSema (similar to overall population) Safety profile consistent across ethnicities GI tolerability similar but potentially lower discontinuation rates in Asian populations Clinical Significance: Supports global applicability of cagrilintide-based therapies across diverse populations
Chemistry and biology of DNA containing 1,N(2)-deoxyguanosine adducts of the alpha,beta-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal
If more is needed: 8 units (200mcg) Frequency Starting: 4 units, 5x/week
Additionally, eryptosis triggered by nanoscale materials can be associated with caspase-3 activation [452, 454] and calpain involvement [453, 458]
Recommendations are based on provider evaluation, clinical judgment, and patient eligibility